Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2023-11-22 Board/Management Inform…
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding the appointment of a senior management personnel, Dr. Sharadsrikar V. Kotturi, as Chief Scientific Officer. It references compliance with Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure of material events including changes in senior management. The content includes details about the appointment, the individual's profile, and the effective date. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a management change rather than a full report or presentation. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this appointment, confirming the classification with high confidence.
2023-11-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings call held on November 7, 2023, for the quarter and half year ended September 30, 2023. It includes management commentary on financial results, business trends, and a Q&A session with analysts. The text explicitly mentions it is an "Earnings Conference Call" transcript and contains detailed financial figures, operational commentary, and forward-looking statements typical of earnings call transcripts. There is no indication that this is a brief announcement or a report publication notice. Therefore, the document fits the category of a Call Transcript (CT).
2023-11-13 English
Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges under Regulation 30 of SEBI Listing Regulations, which mandates disclosure of material events. The content details the Board of Directors' approval of a capital expenditure plan for capacity expansion, including investment amount, financing mode, and timeline. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is a notification of a capital expenditure decision, which fits the category of Capital/Financing Update (CAP). The document length is short (1863 characters), and it is not an announcement of a report publication but a direct update on financing activity.
2023-11-10 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter and half year ended September 30, 2023. It includes extracts of consolidated unaudited financial results with key financial figures such as total income, net profit before and after tax, comprehensive income, equity share capital, and earnings per share. The document references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document is essentially a newspaper advertisement extract of unaudited quarterly and half-year financial results, not a full interim report with detailed financial statements and analysis. It is a formal announcement of financial results rather than the comprehensive report itself. Therefore, it fits best under the category of Earnings Release (ER), which covers initial announcements of quarterly/periodical financial results with key highlights only. H1 2024
2023-11-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a letter addressed to stock exchanges regarding the audio recordings of an earnings call conducted on November 7, 2023, for the quarter and half year ended September 30, 2023. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The content is an announcement about the earnings call audio availability, not the earnings release or transcript. Therefore, it fits best under Call Transcript (CT) category as it relates to the earnings call, but since it only provides the audio link and not the transcript, it is more of an announcement related to the call. However, given the options, the closest and most appropriate classification is Call Transcript (CT) because it pertains directly to the earnings call event and its recording.
2023-11-07 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter and half year ended September 30, 2023. It includes detailed financial summary data such as total income, EBITDA, PAT, and EPS for Q2FY24 and H1FY24, with year-over-year and quarter-over-quarter growth percentages. The document also mentions an upcoming earnings call to discuss these results. The presence of detailed financial figures and the focus on quarterly results indicate this is an Earnings Release (ER). The document is about 5,055 characters, which is typical for an earnings release and not a full interim report. It is not a transcript, management discussion, or annual report. Therefore, the correct classification is Earnings Release (ER). Q2 2024
2023-11-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.